MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Essential Tremor and Depression

S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill (Phoenix, AZ, USA)

Meeting: 2017 International Congress

Abstract Number: 756

Keywords: Depression, Essential tremor(ET)

Session Information

Date: Tuesday, June 6, 2017

Session Title: Tremor

Session Time: 1:45pm-3:15pm

Location: Exhibit Hall C

Objective: To determine if depression and neuropsychiatric symptoms are more prevalent in patients with essential tremor (ET) compared with non-ET controls and if so, to establish the role of disease severity in regard to these symptoms.

Background: ET is the most prevalent movement disorder with well characterized motor symptomatology but limited data on the non-motor manifestations. While depression has been well studied in other common movement disorders such as Parkinson’s Disease, there has been limited evaluation of the prevalence of depression in ET. 

Methods: We compared 104 ET subjects with 481 non-ET controls involved in the Arizona Study of Aging and Neurodegenerative Disorders. An analysis of baseline depression scales and neuropsychiatric inventory (NPI) was done between the two groups and additionally within the ET group for those with and without subjectively distressing tremors, and above and below the median duration of tremor for the group.

Results: There was no statistically significant difference in GDS, HAMD, and NPI total severity scores between ET and non-ET groups. There were also no noted differences in the NPI positive measures between the two groups, including scores for depression, anxiety, apathy, or irritability. While more subjects in the ET group seemed to be previously or currently treated for depression based on medical history, this difference did not reach statistical significance. Among the ET group with subjectively distressing tremors (UPDRS II tremor score >1), there was also no statistically significant difference reported in GDS, HAMD, and NPI total severity scores.  Depression and neuropsychiatric assessment scores were also reviewed within the ET group above and below median tremor duration, as well as on severity based on FTM scale with no significant differences noted.

Conclusions: Essential tremor does not seem to be associated with a higher prevalence of depression or other neuropsychiatric symptoms compared to non-ET controls in a well categorized group from the AZSAND database.

To cite this abstract in AMA style:

S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill. Essential Tremor and Depression [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/essential-tremor-and-depression/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/essential-tremor-and-depression/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley